TABLE 2.
Top 10 reactome pathways that enriched for IAV, IBV, or RV infection when compared with mock infection at 12 hpi using g:Profiler analysis.
IAV | IBV | RV | |||||||
Reactome pathway | FDR-adjusted p-value | Enrichment score | Reactome pathway | FDR-adjusted p-value | Enrichment score | Reactome pathway | FDR-adjusted p-value | Enrichment score | |
1 | Interferon signaling | 2.1E-27 | 26.69 | Cell cycle | 1.4E-20 | 19.86 | Interferon signaling | 4.0E-25 | 24.39 |
2 | Cytokine signaling in immune system | 4.1E-27 | 26.38 | Influenza infection | 1.7E-20 | 19.78 | Interferon alpha/beta signaling | 2.5E-22 | 21.60 |
3 | Interferon alpha/beta signaling | 1.3E-24 | 23.90 | L13a-mediated translational silencing of ceruloplasmin expression | 2.6E-20 | 19.58 | Cytokine signaling in immune system | 1.2E-17 | 16.92 |
4 | Immune system | 2.3E-21 | 20.64 | Cytokine signaling in immune system | 3.4E-20 | 19.47 | Interferon gamma signaling | 8.4E-13 | 12.08 |
5 | Eukaryotic translation elongation | 7.4E-20 | 19.13 | Cap-dependent translation initiation | 4.4E-20 | 19.35 | Immune system | 1.9E-08 | 7.72 |
6 | Peptide chain elongation | 7.4E-20 | 19.13 | Eukaryotic translation initiation | 4.4E-20 | 19.35 | Interleukin-4 and Interleukin-13 signaling | 6.1E-07 | 6.21 |
7 | Viral mRNA translation | 7.4E-20 | 19.13 | Influenza life cycle | 6.5E-20 | 19.18 | Interleukin-10 signaling | 8.5E-06 | 5.07 |
8 | Nonsense mediated decay (NMD) enhanced by EJC | 1.4E-19 | 18.85 | Signaling by ROBO receptors | 8.8E-20 | 19.06 | Antiviral mechanism by IFN-stimulated genes | 2.0E-05 | 4.70 |
9 | Nonsense-mediated decay (NMD) | 1.4E-19 | 18.85 | Cell cycle. Mitotic | 1.1E-19 | 18.95 | FOXO-mediated transcription | 9.4E-05 | 4.03 |
10 | Influenza infection | 1.6E-19 | 18.79 | GTP hydrolysis and joining of the 60S ribosomal subunit | 1.8E-19 | 18.74 | Signaling by interleukins | 1.5E-04 | 3.82 |